Q2 2026 Holdings
Filed 2026-07-28 | 10 holdings | $534.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| MeiraGTx Holdings plc(MGTX) | COM | G59665102 | $164.8M | 12,197,737 | 30.9% |
| Inhibrx Biosciences, Inc.(INBX) | COM | 45720N103 | $109.7M | 1,157,926 | 20.5% |
| Novavax(NVAX) | COM NEW | 670002401 | $64.8M | 6,880,481 | 12.1% |
| AnaptysBio(ANAB) | COM | 032724106 | $55.5M | 821,917 | 10.4% |
| Odyssey Therapeutics Inc.(ODTX) | COMMON STOCK | 67613T104 | $37.3M | 1,991,918 | 7.0% |
| Agomab Therapeutics NV(AGMB) | SPONSORED ADS | 00860C102 | $36.1M | 2,783,096 | 6.8% |
| MapLight Therapeutics Inc.(MPLT) | COM | 56565P103 | $32.7M | 912,041 | 6.1% |
| First Tracks Biotherapeutics Inc.(TRAX) | ORD SHS | 337185102 | $16.5M | 821,917 | 3.1% |
| Immuneering Corp(IMRX) | CLASS A COM | 45254E107 | $13.5M | 2,708,559 | 2.5% |
| Q32 Bio Inc.(QTTB) | COM | 746964105 | $3.1M | 244,083 | 0.6% |